The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Stefanchik John, individually and as an officer and director of Beringer Corporation, et al.
Renown Health: Analysis of Agreement Containing Consent Order to Aid Public Comment; Proposed Consent Agreement
20121146: Walgreen Co.; Stephen L. LaFrance
First Universal Lending, LLC, et al.
Statement of Commissioner Rosch, Concurring in Part and Dissenting in Part - In the Matter of McWane, Inc., a corporation, and Star Pipe Products, Ltd
20121089: AT&T Inc.; Cavalier Wireless, LLC
20121175: Henri Audet; ABRY Partners IV, L.P.
20121101: 3M Company; Federal Signal Corporation
1208001 Informal Interpretation
Johnson & Johnson / Synthes, Inc.
The FTC required Johnson & Johnson (J&J) to sell its system for surgically treating serious wrist fractures, resolving charges that J&J's proposed $21.3 billion acquisition of Synthes, Inc. would illegally reduce competition for these systems. J&J intends to sell its system, known as DVR, along with the rest of its product line for treating traumatic injuries, to Biomet, Inc. According to the FTC's complaint, J&J's proposed acquisition of Synthes would harm competition in the U.S. market for volar distal radius plating systems, internal devices that are surgically implanted on the underside of the wrist to achieve proper alignment of the radius bone following a fracture.